Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CXXIF Stock Summary
In the News

C21 Investments Reports Slightly Lower Q3 Revenue, 10th Straight Quarter Of Positive Free Cash Flow
Vertically integrated cannabis company C21 Investments Inc. (CSE:CXXI) (OTCQX:CXXIF) announced its unaudited results on Thursday for the third quarter ended October 31, 2021. "C21 continues to deliver positive free cash flow and profitable bottom-line performance," Sonny Newman, the company's president and CEO said.

C21 Announces Release Date of Fiscal Year End Financial Results
Provides Cultivation Expansion Update and Sees Record Retail Revenue for March at its Nevada DispensariesVancouver, British Columbia--(Newsfile Corp. - April 15, 2021) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically-integrated cannabis company today announces it will release its year end (fiscal period ending January 31, 2021) audited financial results on May 18, 2021.The Company has received the requisite approvals for the first phase of its Nevada cultivation expansion (see news release dated December 2, 2020), with five new flowering and vegetative rooms currently under...

5 Reasons Why C21 Investments Is Ready To Take On The Big Cannabis MSOs
C21 Investments Inc. (OTCQX:CXXIF), an American cannabis company and multi-state operator (MSO) with a presence in Nevada and Oregon, has seen its shares soar over 100% in the past few months. With an eye on the potential for federal cannabis reform under the Biden administration, investors are watching for the next big U.S. cannabis player to emerge and C21 fits the bill.

C21 Investments Checks All The Boxes And Is Profitable; It Is Love At First Sight
C21 Investments Checks All The Boxes And Is Profitable; It Is Love At First Sight
CXXIF Financial details
CXXIF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-01-31
Metric | History | 2018-01-31 | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0.08 | 0.49 | 0.34 | 0.28 | |
Net income per share | -0.13 | -0.76 | -0.42 | -0.06 | 0.09 | |
Operating cash flow per share | -0.1 | -0.37 | 0.07 | 0.09 | 0.06 | |
Free cash flow per share | -0.1 | -0.37 | 0.07 | 0.09 | 0.04 | |
Cash per share | 0.04 | 0.29 | 0.04 | 0.06 | 0.03 | |
Book value per share | 0.01 | 0.68 | 0.18 | 0.24 | 0.3 | |
Tangible book value per share | 0.01 | -0.69 | -0.36 | -0.14 | -0.02 | |
Share holders equity per share | 0.01 | 0.68 | 0.18 | 0.24 | 0.3 | |
Interest debt per share | 0 | 1.65 | 0.53 | 0.3 | 0.17 | |
Market cap | 8.19M | 66.31M | 38.1M | 127.23M | 53.24M | |
Enterprise value | 7.98M | 107.16M | 71.09M | 148.29M | 68.84M | |
P/E ratio | -13.06 | -2.81 | -1.17 | -20.84 | 4.88 | |
Price to sales ratio | 0 | 25.65 | 1.01 | 3.52 | 1.61 | |
POCF ratio | -15.75 | -5.83 | 6.91 | 12.82 | 7.79 | |
PFCF ratio | -15.75 | -5.73 | 7.62 | 13.12 | 12.46 | |
P/B Ratio | 117.09 | 3.14 | 2.81 | 5.02 | 1.52 | |
PTB ratio | 117.09 | 3.14 | 2.81 | 5.02 | 1.52 | |
EV to sales | 0 | 41.45 | 1.89 | 4.1 | 2.09 | |
Enterprise value over EBITDA | -12.73 | -5.02 | 17.73 | 11.8 | 5.89 | |
EV to operating cash flow | -15.35 | -9.43 | 12.9 | 14.94 | 10.07 | |
EV to free cash flow | -15.35 | -9.25 | 14.22 | 15.29 | 16.11 | |
Earnings yield | -0.08 | -0.36 | -0.85 | -0.05 | 0.21 | |
Free cash flow yield | -0.06 | -0.17 | 0.13 | 0.08 | 0.08 | |
Debt to equity | 2.98 | 2.67 | 3.53 | 1.72 | 0.77 | |
Debt to assets | 0.75 | 0.73 | 0.78 | 0.63 | 0.43 | |
Net debt to EBITDA | 0.33 | -1.91 | 8.23 | 1.68 | 1.34 | |
Current ratio | 1.52 | 0.58 | 0.3 | 0.99 | 0.7 | |
Interest coverage | 0 | -8.69 | -0.23 | 1.68 | 7.46 | |
Income quality | 0.83 | 0.48 | -0.17 | -2.65 | 0.52 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 3.42 | 0.27 | 0.21 | 0.24 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.55 | 0.67 | 0.57 | 0.61 | |
Capex to operating cash flow | 0 | 0.02 | -0.09 | -0.02 | -0.37 | |
Capex to revenue | 0 | -0.08 | -0.01 | -0.01 | -0.08 | |
Capex to depreciation | 0 | -0.24 | -0.1 | -0.07 | -1.41 | |
Stock based compensation to revenue | 0 | 1.77 | 0.01 | 0.01 | 0.01 | |
Graham number | 0.2 | 3.41 | 1.3 | 0.56 | 0.78 | |
ROIC | 2.56 | -0.21 | -0.02 | 0.22 | 0.14 | |
Return on tangible assets | -2.25 | -0.68 | -1.61 | -0.21 | 0.45 | |
Graham Net | 0 | -1.38 | -0.53 | -0.32 | -0.18 | |
Working capital | 78.68K | -13.32M | -26.95M | -144.72K | -4.44M | |
Tangible asset value | 69.94K | -21.51M | -27.67M | -14.16M | -2.78M | |
Net current asset value | 21.7K | -37.86M | -36.21M | -27.89M | -16.59M | |
Invested capital | 0 | 2.37 | 2.66 | 1.08 | 0.53 | |
Average receivables | 8.21K | 46.02K | 261.54K | 326.5K | 210.15K | |
Average payables | 206.28K | 752.59K | 1.27M | 1.26M | 1.39M | |
Average inventory | 0 | 4.36M | 8.16M | 7.18M | 5.41M | |
Days sales outstanding | 0 | 11.29 | 4.29 | 2.12 | 2.33 | |
Days payables outstanding | 0 | 212.38 | 17.02 | 28.88 | 36.12 | |
Days of inventory on hand | 0 | 1.33K | 113.77 | 141.16 | 104.42 | |
Receivables turnover | 0 | 32.34 | 85.09 | 172.14 | 156.75 | |
Payables turnover | 0 | 1.72 | 21.45 | 12.64 | 10.11 | |
Inventory turnover | 0 | 0.28 | 3.21 | 2.59 | 3.5 | |
ROE | -8.97 | -1.12 | -2.4 | -0.24 | 0.31 | |
Capex per share | 0 | -0.01 | -0.01 | 0 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-02-13 for Q4
Metric | History | 2022-01-31 | 2022-04-30 | 2022-07-31 | 2022-10-31 | 2023-02-13 |
---|---|---|---|---|---|---|
Revenue per share | 0.06 | 0.06 | 0.06 | 0.06 | 0 | |
Net income per share | 0.02 | 0.01 | 0.02 | 0 | 0 | |
Operating cash flow per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Cash per share | 0.03 | 0.02 | 0.02 | 0.02 | 0 | |
Book value per share | 0.3 | 0.29 | 0.31 | 0.31 | 0 | |
Tangible book value per share | -0.02 | -0.02 | 0 | 0.01 | 0 | |
Share holders equity per share | 0.3 | 0.29 | 0.31 | 0.31 | 0 | |
Interest debt per share | 0.16 | 0.14 | 0.13 | 0.12 | 0 | |
Market cap | 53.24M | 48.44M | 35M | 26.66M | 0 | |
Enterprise value | 68.84M | 63.01M | 48.13M | 38.1M | 0 | |
P/E ratio | 7.46 | 11.68 | 4.71 | 26.82 | 0 | |
Price to sales ratio | 7.95 | 6.48 | 4.88 | 3.7 | 0 | |
POCF ratio | 41.1 | 32.18 | 19.97 | 18.49 | 0 | |
PFCF ratio | 44.86 | 43.46 | 20.33 | 18.64 | 0 | |
P/B Ratio | 1.52 | 1.37 | 0.94 | 0.71 | 0 | |
PTB ratio | 1.52 | 1.37 | 0.94 | 0.71 | 0 | |
EV to sales | 10.27 | 8.43 | 6.71 | 5.29 | 0 | |
Enterprise value over EBITDA | 22.55 | 29.17 | 24.3 | 20.88 | 0 | |
EV to operating cash flow | 53.15 | 41.86 | 27.46 | 26.43 | 0 | |
EV to free cash flow | 58 | 56.53 | 27.96 | 26.63 | 0 | |
Earnings yield | 0.03 | 0.02 | 0.05 | 0.01 | 0 | |
Free cash flow yield | 0.02 | 0.02 | 0.05 | 0.05 | 0 | |
Debt to equity | 0.77 | 0.74 | 0.66 | 0.63 | 0 | |
Debt to assets | 0.43 | 0.43 | 0.4 | 0.39 | 0 | |
Net debt to EBITDA | 5.11 | 6.74 | 6.63 | 6.27 | 0 | |
Current ratio | 0.7 | 0.64 | 0.68 | 0.73 | 0 | |
Interest coverage | 35.08 | 10.33 | 11.42 | 13.94 | 0 | |
Income quality | -2.63 | 1.45 | 1.16 | 6.07 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.32 | 0.26 | 0.28 | 0.3 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.61 | 0.61 | 0.6 | 0.6 | 0 | |
Capex to operating cash flow | -0.08 | -0.26 | -0.02 | -0.01 | 0 | |
Capex to revenue | -0.02 | -0.05 | 0 | 0 | 0 | |
Capex to depreciation | 0.4 | -0.85 | -0.07 | -0.02 | 0 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Graham number | 0.32 | 0.24 | 0.33 | 0.12 | 0 | |
ROIC | 0.03 | 0.02 | 0.02 | 0 | 0 | |
Return on tangible assets | 0.07 | 0.04 | 0.08 | 0.01 | 0 | |
Graham Net | -0.18 | -0.18 | -0.16 | -0.15 | 0 | |
Working capital | -4.44M | -5.68M | -4.82M | -3.9M | 0 | |
Tangible asset value | -2.78M | -2.04M | -9.3K | 910.68K | 0 | |
Net current asset value | -16.59M | -16.2M | -14.18M | -13.01M | 0 | |
Invested capital | 0.53 | 0.48 | 0.42 | 0.36 | 0 | |
Average receivables | 222.09K | 294.56K | 304.94K | 246K | 130.42K | |
Average payables | 1.57M | 1.47M | 1.48M | 1.4M | 687.53K | |
Average inventory | 5.85M | 4.39M | 5.07M | 5.48M | 2.77M | |
Days sales outstanding | 2.83 | 4.56 | 2.9 | 3.26 | 0 | |
Days payables outstanding | 76.06 | 39.87 | 38.69 | 37.47 | 0 | |
Days of inventory on hand | 219.87 | 122.09 | 146.96 | 151.2 | 0 | |
Receivables turnover | 31.84 | 19.73 | 31.04 | 27.63 | 0 | |
Payables turnover | 1.18 | 2.26 | 2.33 | 2.4 | 0 | |
Inventory turnover | 0.41 | 0.74 | 0.61 | 0.6 | 0 | |
ROE | 0.05 | 0.03 | 0.05 | 0.01 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CXXIF Frequently Asked Questions
What is C21 Investments Inc. stock symbol ?
C21 Investments Inc. is a CA stock , located in Vancouver of Bc and trading under the symbol CXXIF
What is C21 Investments Inc. stock quote today ?
C21 Investments Inc. stock price is $0.28104 today.
Is C21 Investments Inc. stock public?
Yes, C21 Investments Inc. is a publicly traded company.